Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Gross Margin (2016 - 2025)

Standard Biotools (LAB) has disclosed Gross Margin for 16 consecutive years, with 47.83% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 200.0% to 47.83% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 48.38% through Dec 2025, down 214.0% year-over-year, with the annual reading at 49.86% for FY2025, 54.0% up from the prior year.
  • Gross Margin for Q4 2025 was 47.83% at Standard Biotools, down from 48.51% in the prior quarter.
  • The five-year high for Gross Margin was 94.71% in Q3 2021, with the low at 23.58% in Q2 2022.
  • Average Gross Margin over 5 years is 54.19%, with a median of 48.51% recorded in 2025.
  • Peak annual rise in Gross Margin hit 4860bps in 2021, while the deepest fall reached -35498bps in 2021.
  • Over 5 years, Gross Margin stood at 94.71% in 2021, then tumbled by -56bps to 41.33% in 2022, then increased by 15bps to 47.39% in 2023, then dropped by -3bps to 45.84% in 2024, then rose by 4bps to 47.83% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 47.83%, 48.51%, and 48.84% for Q4 2025, Q3 2025, and Q2 2025 respectively.